137 related articles for article (PubMed ID: 15721301)
1. Quantitative measurement of changes in adhesion force involving focal adhesion kinase during cell attachment, spread, and migration.
Wu CC; Su HW; Lee CC; Tang MJ; Su FC
Biochem Biophys Res Commun; 2005 Apr; 329(1):256-65. PubMed ID: 15721301
[TBL] [Abstract][Full Text] [Related]
2. Involvement of focal adhesion kinase in hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells.
Lai JF; Kao SC; Jiang ST; Tang MJ; Chan PC; Chen HC
J Biol Chem; 2000 Mar; 275(11):7474-80. PubMed ID: 10713050
[TBL] [Abstract][Full Text] [Related]
3. Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF.
Rovida E; Lugli B; Barbetti V; Giuntoli S; Olivotto M; Dello Sbarba P
Biol Chem; 2005 Sep; 386(9):919-29. PubMed ID: 16164417
[TBL] [Abstract][Full Text] [Related]
4. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
[TBL] [Abstract][Full Text] [Related]
5. FAK phosphorylation at Ser-843 inhibits Tyr-397 phosphorylation, cell spreading and migration.
Jacamo R; Jiang X; Lunn JA; Rozengurt E
J Cell Physiol; 2007 Feb; 210(2):436-44. PubMed ID: 17096371
[TBL] [Abstract][Full Text] [Related]
6. Dynamic conformational changes in the FERM domain of FAK are involved in focal-adhesion behavior during cell spreading and motility.
Papusheva E; Mello de Queiroz F; Dalous J; Han Y; Esposito A; Jares-Erijmanxa EA; Jovin TM; Bunt G
J Cell Sci; 2009 Mar; 122(Pt 5):656-66. PubMed ID: 19208768
[TBL] [Abstract][Full Text] [Related]
7. Integrin beta1-mediated signaling is involved in transforming growth factor-beta2-promoted migration in human lens epithelial cells.
Yao K; Tan J; Ye P; Wang K; Xu W; ShenTu X; Tang X
Mol Vis; 2007 Sep; 13():1769-76. PubMed ID: 17960115
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effect of EGF on FAK phosphorylation/dephosphorylation in a cell.
Kim SH; Kim SH
Cell Biochem Funct; 2008; 26(5):539-47. PubMed ID: 18543351
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucocorticoid-induced osteoporotic-like conditions on osteoblast cell attachment to implant surface microtopographies.
Cho P; Schneider GB; Kellogg B; Zaharias R; Keller JC
Implant Dent; 2006 Dec; 15(4):377-85. PubMed ID: 17172956
[TBL] [Abstract][Full Text] [Related]
11. [FAK related non-kinase (FRNK) inhibits migration of a human breast carcinoma cell line MDA-MB-435].
Qin J; Liu ZX
Ai Zheng; 2006 Jul; 25(7):833-8. PubMed ID: 16831273
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion.
Chen SY; Chen HC
Mol Cell Biol; 2006 Jul; 26(13):5155-67. PubMed ID: 16782899
[TBL] [Abstract][Full Text] [Related]
13. Disruption of FRNK expression by gene targeting of the intronic promoter within the focal adhesion kinase gene.
Hayasaka H; Martin KH; Hershey ED; Parsons JT
J Cell Biochem; 2007 Nov; 102(4):947-54. PubMed ID: 17440961
[TBL] [Abstract][Full Text] [Related]
14. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.
Cox BD; Natarajan M; Stettner MR; Gladson CL
J Cell Biochem; 2006 Sep; 99(1):35-52. PubMed ID: 16823799
[TBL] [Abstract][Full Text] [Related]
15. Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells.
Earley S; Plopper GE
Biochem Biophys Res Commun; 2006 Nov; 350(2):405-12. PubMed ID: 17010315
[TBL] [Abstract][Full Text] [Related]
16. [Dynamic changes in focal adhesion kinase during cell migration induced by bFGF and the significance].
Liang GB; Zhang GP; Jin HM; Qian RZ
Sheng Li Xue Bao; 2004 Aug; 56(4):509-14. PubMed ID: 15322688
[TBL] [Abstract][Full Text] [Related]
17. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
18. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
[TBL] [Abstract][Full Text] [Related]
19. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase promotes the aggressive melanoma phenotype.
Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
